Equities Research Analysts’ Updated EPS Estimates for June 3rd (ARVN, ATO, BBIO, CAML, CHG, CIM, COST, CRDF, CTRN, CURY)

Equities Research Analysts’ updated eps estimates for Wednesday, June 3rd:

Arvinas (NASDAQ:ARVN) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $18.00 target price on the stock.

Atmos Energy (NYSE:ATO) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Canaccord Genuity Group Inc. began coverage on shares of BridgeBio Pharma (NASDAQ:BBIO). Canaccord Genuity Group Inc. issued a buy rating and a $104.00 price target on the stock.

Central Asia Metals (LON:CAML) had its hold rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 190 target price on the stock.

Chemring Group (LON:CHG) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 650 price target on the stock.

Chimera Investment (NYSE:CIM) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $14.00 target price on the stock.

Costco Wholesale (NASDAQ:COST) had its buy rating reissued by analysts at TD Cowen. They currently have a $1,175.00 target price on the stock.

Cardiff Oncology (NASDAQ:CRDF) was downgraded by analysts at Craig Hallum from a buy rating to a hold rating. The firm currently has $2.00 target price on the stock.

Citi Trends (NASDAQ:CTRN) had its buy rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $68.00 target price on the stock.

Currys (LON:CURY) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 210 price target on the stock.

DZ Bank AG started coverage on shares of Danaher (NYSE:DHR). The firm issued a buy rating and a $210.00 price target on the stock.

Elementis (LON:ELM) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 200 price target on the stock.

Entain (LON:ENT) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 1,200 price target on the stock.

Everplay Group (LON:EVPL) had its buy rating reiterated by analysts at Shore Capital Group Ltd. They currently have a GBX 430 price target on the stock.

FirstService (NASDAQ:FSV) (TSE:FSV) had its buy rating reaffirmed by analysts at TD Cowen. The firm currently has a $204.00 price target on the stock.

Fulcrum Therapeutics (NASDAQ:FULC) had its underweight rating reissued by analysts at JPMorgan Chase & Co..

First Watch Restaurant Group (NASDAQ:FWRG) had its buy rating reaffirmed by analysts at TD Cowen. The firm currently has a $17.00 target price on the stock.

GB Group (LON:GBG) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 415 target price on the stock.

Alphabet (NASDAQ:GOOGL) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $450.00 price target on the stock.

GitLab (NASDAQ:GTLB) had its hold rating reissued by analysts at TD Cowen. They currently have a $29.00 target price on the stock.

HIVE Digital Technologies (NASDAQ:HIVE) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $7.00 target price on the stock.

Needham & Company LLC initiated coverage on shares of Horizon Quantum Computing Pte. (NASDAQ:HQ). Needham & Company LLC issued a buy rating and a $20.00 price target on the stock.

Howden Joinery Group (LON:HWDN) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 1,000 price target on the stock.

Intermediate Capital Group (LON:ICG) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 2,800 price target on the stock.

Kura Sushi USA (NASDAQ:KRUS) had its hold rating reiterated by analysts at TD Cowen. TD Cowen currently has a $58.00 price target on the stock.

Kyverna Therapeutics (NASDAQ:KYTX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $25.00 target price on the stock.

LeMaitre Vascular (NASDAQ:LMAT) had its outperform rating reissued by analysts at Barrington Research. The firm currently has a $120.00 target price on the stock.

JPMorgan Chase & Co. started coverage on shares of LATAM Airlines Group (NYSE:LTM). The firm issued an overweight rating and a $70.00 price target on the stock.

Innovative Eyewear (NASDAQ:LUCY) had its hold rating reissued by analysts at Maxim Group.

Lyell Immunopharma (NASDAQ:LYEL) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $45.00 target price on the stock.

Mastercard (NYSE:MA) had its buy rating reissued by analysts at Loop Capital. They currently have a $631.00 price target on the stock.

TD Cowen started coverage on shares of Merlin, Inc. Common Stock (NASDAQ:MRLN). They issued a buy rating and a $11.00 price target on the stock.

Annaly Capital Management (NYSE:NLY) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $25.00 target price on the stock.

NU (NYSE:NU) was downgraded by analysts at Susquehanna from a positive rating to a neutral rating. They currently have $13.00 target price on the stock, down from their previous target price of $18.00.

ODDITY Tech (NASDAQ:ODD) had its sector weight rating reissued by analysts at KeyCorp.

ODDITY Tech (NASDAQ:ODD) had its sell rating reiterated by analysts at The Goldman Sachs Group, Inc.. The firm currently has a $8.00 target price on the stock, down from their previous target price of $16.00.

Oxford Biomedica (LON:OXB) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 1,170 price target on the stock.

Paragon Banking Group (LON:PAG) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a GBX 1,050 target price on the stock.

Paragon Banking Group (LON:PAG) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 1,100 price target on the stock.

PMI (NYSEAMERICAN:PMI) had its neutral rating reiterated by analysts at HC Wainwright.

RealReal (NASDAQ:REAL) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $17.00 price target on the stock.

Rivian Automotive (NASDAQ:RIVN) had its buy rating reiterated by analysts at TD Cowen. They currently have a $20.00 price target on the stock.

Rockhopper Exploration (LON:RKH) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 130 price target on the stock.

Truist Financial Corporation initiated coverage on shares of Construction Partners (NASDAQ:ROAD). The firm issued a hold rating and a $130.00 target price on the stock.

Repay (NASDAQ:RPAY) had its buy rating reissued by analysts at DA Davidson. They currently have a $6.00 target price on the stock.

RS Group (LON:RS1) had its hold rating reiterated by analysts at Berenberg Bank. They currently have a GBX 600 target price on the stock.

Rezolute (NASDAQ:RZLT) was upgraded by analysts at Citizens Jmp from a market perform rating to an outperform rating. The firm currently has $11.00 price target on the stock.

Shake Shack (NYSE:SHAK) had its hold rating reaffirmed by analysts at TD Cowen. The firm currently has a $70.00 price target on the stock.

Snowflake (NYSE:SNOW) had its buy rating reissued by analysts at TD Cowen. They currently have a $300.00 price target on the stock.

Silver Standard Resources (NASDAQ:SSRM) (TSE:SSO) was upgraded by analysts at Royal Bank Of Canada from a sector perform rating to an outperform rating. The firm currently has $40.00 target price on the stock, down from their previous target price of $45.00.

Northland Securities assumed coverage on shares of T1 Energy (NYSE:TE). The firm issued an outperform rating and a $16.00 target price on the stock.

Travere Therapeutics (NASDAQ:TVTX) had its outperform rating reissued by analysts at Wedbush. They currently have a $55.00 price target on the stock.

Urogen Pharma (NASDAQ:URGN) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $45.00 target price on the stock.

Walmart (NASDAQ:WMT) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $145.00 target price on the stock.

Yesway (NASDAQ:YSWY) had its buy rating reissued by analysts at Guggenheim.

Zymeworks (NASDAQ:ZYME) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $46.00 target price on the stock.